| scholarly article | Q13442814 |
| P2093 | author name string | C Zhu | |
| B Wang | |||
| J Yu | |||
| Z Yang | |||
| K Davis | |||
| H Rios | |||
| E C Boedeker | |||
| G Glenn | |||
| P2860 | cites work | Antibacterials that are used as growth promoters in animal husbandry can affect the release of Shiga-toxin-2-converting bacteriophages and Shiga toxin 2 from Escherichia coli strains. | Q54049938 |
| Role of Shiga-like toxin I in bacterial enteritis: comparison between isogenic Escherichia coli strains induced in rabbits. | Q54641094 | ||
| Verotoxin receptor glycolipid in human renal tissue. | Q54736253 | ||
| Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells | Q57184743 | ||
| Development of a hybrid Shiga holotoxoid vaccine to elicit heterologous protection against Shiga toxins types 1 and 2☆ | Q57563815 | ||
| Skin immunization made possible by cholera toxin | Q59075425 | ||
| Monoclonal antibodies against Galα 1 −4Galß 1 −4Glc(Pk, CD77) produced with a synthetic glycoconjugate as immunogen: Reactivity with carbohydrates, with fresh frozen human tissues and hematopoietic tumors | Q67926556 | ||
| Transcutaneous immunization with cholera toxin protects mice against lethal mucosal toxin challenge | Q77367580 | ||
| Diarrheagenic Escherichia coli | Q24533466 | ||
| Evidence that glutamic acid 167 is an active-site residue of Shiga-like toxin I | Q24651553 | ||
| Food-related illness and death in the United States | Q29615940 | ||
| Pathogenic Escherichia coli | Q29616738 | ||
| Shiga toxin: biochemistry, genetics, mode of action, and role in pathogenesis | Q33350981 | ||
| Infection by Shiga toxin-producing Escherichia coli: an overview | Q33358878 | ||
| Renal injury is a consistent finding in Dutch Belted rabbits experimentally infected with enterohemorrhagic Escherichia coli | Q33370593 | ||
| The Epidemiology of Infections Caused by Escherichia coli O157: H7, Other Enterohemorrhagic E. coli, and the Associated Hemolytic Uremic Syndrome | Q33375970 | ||
| The pathogenic mechanisms of Shiga toxin and the Shiga-like toxins | Q33376042 | ||
| Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools | Q33475757 | ||
| Endothelial heterogeneity in Shiga toxin receptors and responses. | Q33493734 | ||
| Enterohemorrhagic Escherichia coli: a family of emerging pathogens | Q33498934 | ||
| Strain-specific differences in the amount of Shiga toxin released from enterohemorrhagic Escherichia coli O157 following exposure to subinhibitory concentrations of antimicrobial agents. | Q33505061 | ||
| Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice. | Q33889513 | ||
| Dendritic-cell trafficking to lymph nodes through lymphatic vessels | Q33989067 | ||
| Complete nucleotide sequence and analysis of the locus of enterocyte Effacement from rabbit diarrheagenic Escherichia coli RDEC-1. | Q34006697 | ||
| Transcutaneous immunization using colonization factor and heat-labile enterotoxin induces correlates of protective immunity for enterotoxigenic Escherichia coli | Q34119379 | ||
| Comparison of Shiga-like toxin I B-subunit expression and localization in Escherichia coli and Vibrio cholerae by using trc or iron-regulated promoter systems | Q34527617 | ||
| Shiga toxin of enterohemorrhagic Escherichia coli type O157:H7 promotes intestinal colonization. | Q34667008 | ||
| Bovine immune response to shiga-toxigenic Escherichia coli O157:H7 | Q35216120 | ||
| Transcutaneous immunization and immunostimulant strategies | Q35643956 | ||
| Mutational analysis of the Shiga toxin and Shiga-like toxin II enzymatic subunits | Q36165342 | ||
| Construction of stable LamB-Shiga toxin B subunit hybrids: analysis of expression in Salmonella typhimurium aroA strains and stimulation of B subunit-specific mucosal and serum antibody responses | Q36949679 | ||
| Structure-function analyses of Shiga toxin and the Shiga-like toxins | Q37947130 | ||
| Transcutaneous immunization with bacterial ADP-ribosylating exotoxins as antigens and adjuvants | Q39509949 | ||
| Localization of intravenously administered verocytotoxins (Shiga-like toxins) 1 and 2 in rabbits immunized with homologous and heterologous toxoids and toxin subunits | Q39830255 | ||
| Cell surface-localized nucleolin is a eukaryotic receptor for the adhesin intimin-gamma of enterohemorrhagic Escherichia coli O157:H7. | Q40769297 | ||
| Protection against hemorrhagic colitis in an animal model by oral immunization with isogeneic rabbit enteropathogenic Escherichia coli attenuated by truncating intimin | Q41918883 | ||
| The rabbit as a new reservoir host of enterohemorrhagic Escherichia coli | Q42121058 | ||
| Nucleotide sequence analysis of the structural genes for Shiga-like toxin I encoded by bacteriophage 933J from Escherichia coli | Q42657348 | ||
| Delivery of heterologous protein antigens via hemolysin or autotransporter systems by an attenuated ler mutant of rabbit enteropathogenic Escherichia coli | Q44320998 | ||
| Induction of protective immunity against lethal anthrax challenge with a patch | Q44991997 | ||
| Towards a vaccine for attaching/effacing Escherichia coli: a LEE encoded regulator (ler) mutant of rabbit enteropathogenic Escherichia coli is attenuated, immunogenic, and protects rabbits from lethal challenge with the wild-type virulent strain | Q48124791 | ||
| P433 | issue | 2 | |
| P921 | main subject | Escherichia coli | Q25419 |
| P304 | page(s) | 359-366 | |
| P577 | publication date | 2007-11-14 | |
| P1433 | published in | Clinical and Vaccine Immunology | Q5133811 |
| P1476 | title | Protection against Shiga toxin-producing Escherichia coli infection by transcutaneous immunization with Shiga toxin subunit B | |
| P478 | volume | 15 |
| Q37190873 | A DNA vaccine encoding the enterohemorragic Escherichia coli Shiga-like toxin 2 A2 and B subunits confers protective immunity to Shiga toxin challenge in the murine model |
| Q91609176 | A grading system for local skin reactions developed for clinical trials of an intradermal and transcutaneous ETEC vaccine |
| Q37162021 | Antibody responses elicited in mice immunized with Bacillus subtilis vaccine strains expressing Stx2B subunit of enterohaemorragic Escherichia coli O157:H7. |
| Q36728068 | Biological Activities of Uric Acid in Infection Due to Enteropathogenic and Shiga-Toxigenic Escherichia coli |
| Q33965188 | Neutralizing antibodies to Shiga toxin type 2 (Stx2) reduce colonization of mice by Stx2-expressing Escherichia coli O157:H7. |
| Q33909187 | Options for inactivation, adjuvant, and route of topical administration of a killed, unencapsulated pneumococcal whole-cell vaccine |
| Q53224717 | Recombinant Shiga toxin B subunit elicits protection against Shiga toxin via mixed Th type immune response in mice. |
| Q33768681 | Salmonella enterica serovar Typhimurium vaccine strains expressing a nontoxic Shiga-like toxin 2 derivative induce partial protective immunity to the toxin expressed by enterohemorrhagic Escherichia coli |
| Q45071905 | Secretion of the Shiga toxin B subunit (Stx1B) via an autotransporter protein optimizes the protective immune response to the antigen expressed in an attenuated E. coli (rEPEC E22Δler) vaccine strain |
| Q34025333 | The extent of the uptake of plasmid into the skin determines the immune responses induced by a DNA vaccine applied topically onto the skin. |
| Q35678340 | Transcutaneous DNA immunization following waxing-based hair depilation |
Search more.